Drugs for Alacrima, Achalasia, and Mental Retardation Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 186)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
2 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4 |
|
83-43-2 |
6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
3 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4 |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
4 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 4 |
|
52-21-1 |
|
5 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4 |
|
50-24-8 |
5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
Hydeltrone
|
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
6 |
|
Zonisamide |
Approved, Investigational |
Phase 4 |
|
68291-97-4 |
5734 |
Synonyms:
1-(1,2-benzisoxazol-3-yl)methanesulfonamide
1-(1,2-Benzoxazol-3-Yl)methanesulfonamide
1,2-Benzisoxazole-3-methanesulfonamide
1,2-Benzisoxazole-3-methanesulphonamide
1,2-benzoxazol-3-ylmethanesulfonamide
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-(Sulphamoylmethyl)-1,2-benzisoxazole
3-sulfamoylmethyl-1,2-benzisoxazole
3-Sulfamoylmethyl-1,2-benzisoxazole
68291-97-4
AC-1413
AC1L1L0Q
AC1Q55GQ
AD 810
AD-810
AD-810N
AKOS001312269
benzo[D]Isoxazol-3-yl-methanesulfonamide
Benzo[d]isoxazol-3-yl-methanesulfonamide
benzo[D]Isoxazol-3-yl-methanesulphonamide
BIDD:GT0708
BIDD:PXR0183
Bio-0532
BRD-K48300629-001-03-8
BRN 1077076
C022189
C07504
C8H8N2O3S
CHEBI:10127
CHEMBL750
CI 912
CI-912
CID5734
CPD000596519
D00538
DB00909
E-2090
Elan brand of zonisamide
Elan brand OF zonisamide
|
Exceglan
Excegram
Excegran
Excegran (TN)
FT-0082702
HMS2089O07
HSDB 7293
I06-0495
LS-33637
MLS001195632
MLS001306491
MolPort-002-507-855
NCGC00159319-02
NCGC00159319-03
PD 110843
PD-110843
S1445_Selleck
SAM002548957
SMR000596519
SPR_2
STK711131
Tremode
Trerief
UNII-459384H98V
ZINC00004321
Zonegran
Zonegran, Zonisamide
Zonisamida
Zonisamida [Spanish]
zonisamide
Zonisamide
Zonisamide (JAN/USAN/INN)
Zonisamide (ZNS)
Zonisamide [USAN:BAN:INN:JAN]
zonisamide monosodium
Zonisamide monosodium
Zonisamidum
Zonisamidum [Latin]
|
|
7 |
|
Lamotrigine |
Approved, Investigational |
Phase 4 |
|
84057-84-1 |
3878 |
Synonyms:
3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine
3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-diamino-6-(2,3-Dichlorophenyl)-1,2,4-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-diamino-6-(2,3-Dichlorophenyl)-as-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine
84057-84-1
AC-10298
AC1L1GWT
BIDD:GT0794
Bio-0056
BW 430C
BW-430C
C047781
CHEBI:138727
CHEBI:6367
CHEMBL741
CID3878
CPD000058464
Crisomet
D00354
DB00555
Desitin Brand of Lamotrigine
EINECS 281-901-8
EU-0100688
EUR-1048
Faes Brand of Lamotrigine
GI 267119X
Glaxo Wellcome Brand of Lamotrigine
GlaxoSmithKline Brand of Lamotrigine
GW 273293
HMS2051C10
HMS2089M08
HMS2093P21
HSDB 7526
Juste Brand of Lamotrigine
L 3791
L3791_SIGMA
|
Labileno
Lamictal
Lamictal (TN)
Lamictal Cd
Lamictal CD
Lamictal ODT
Lamictal XR
Lamictin
Lamiktal
Lamitor
Lamotrigina
Lamotrigina [Spanish]
lamotrigine
Lamotrigine
Lamotrigine (JAN/USAN/INN)
Lamotrigine [USAN:INN:BAN]
Lamotriginum
Lamotriginum [Latin]
Lopac0_000688
Lopac-L-3791
LS-155249
MLS000069685
MLS000759486
MLS001077325
MolPort-003-666-744
NCGC00015605-01
NCGC00015605-02
NCGC00015605-06
NCGC00015605-08
NCGC00022936-02
NCGC00022936-04
NCGC00022936-05
NSC746307
SAM001246697
SMP2_000303
SMR000058464
STK628377
Tocris-1611
UNII-U3H27498KS
ZINC00013156
|
|
8 |
|
Rufinamide |
Approved |
Phase 4 |
|
106308-44-5 |
129228 |
Synonyms:
1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxamide
1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide
106308-44-5
AC-1429
AC1L2V8C
AKOS005145897
Banzel
Banzel, Rufinamide
Cgp 33101
CGP-33101
CHEMBL1201754
CID129228
D05775
E-2080
I06-1425
Inovelon
MLS001332513
|
MLS001332514
MolPort-005-942-441
NCGC00165883-01
NCGC00165883-02
NCGC00165883-03
R8404_SIGMA
RUF-331
Rufinamida
Rufinamide
Rufinamide (USAN/INN)
S1256_Selleck
SBB070637
SMR000857122
SYN-111
UNII-WFW942PR79
Xilep
ZINC00007782
|
|
9 |
|
Phenobarbital |
Approved, Investigational |
Phase 4 |
|
50-06-6 |
4763 |
Synonyms:
11097-06-6
46755-67-3
50-06-6
57-30-7 (mono-hydrochloride salt)
5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione
5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-(1H,3H,5H)pyrimidinetrione
5-Ethyl-5-phenyl-2,4,6-pyrimidinetrione
5-Ethyl-5-phenylbarbitate
5-Ethyl-5-phenylbarbitic acid
5-Ethyl-5-phenylbarbituric acid
5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-phenyl-pyrimidine-2,4,6-trione
5-Phenyl-5-ethylbarbitate
5-Phenyl-5-ethylbarbitic acid
5-Phenyl-5-ethylbarbituric acid
AC1L1IWE
Acid, phenylethylbarbituric
Acido 5-fenil-5-etilbarbiturico
Acido 5-fenil-5-etilbarbiturico [Italian]
Adonal
aephe nal
Aephenal
Agrypnal
AI3-02726
AKOS000605404
Amylofene
Antrocol
Aphenylbarbit
Aphenyletten
Arco-Lase Plus
Austrominal
barbapil
barbellen
barbellon
Barbenyl
barbilehae
Barbilehae (barbilettae)
Barbinal
Barbipenyl
Barbiphen
Barbiphenyl
Barbipil
Barbita
Barbivis
Barbonal
Barbophen
Bardorm
Bartol
BAS 00226811
Bialminal
BIDD:PXR0061
Blu-phen
Blu-Phen
C07434
Cabronal
Calmetten
Calminal
Cardenal
CCRIS 502
Chardonna-2
CHEBI:8069
CHEMBL40
Chinoin
CID4763
Codibarbita
component of Antrocol
component of Bronkotabs
component of Hecadrol
component of Primatene P
component of Slowten
component of Tedral
component of Valpin 50-PB
Coronaletta
Cratecil
d ezibarbitur
D00506
Damoral
DB01174
DEA No. 2285
Dezibarbitur
DivK1c_000987
Donphen
Dormina
Dormiral
Dormital
Doscalun
Duneryl
EINECS 200-007-0
Elixir of phenobarbital
Ensobarb
Ensodorm
Epanal
Epidorm
Epilol
Episedal
Epsylone
Eskabarb
Etilfen
Euneryl
fen osed
Fenbital
Fenemal
Fenobarbital
Fenobarbital [INN-Spanish]
Fenobarbitale
Fenobarbitale [DCIT]
Fenosed
Fenylettae
Gardenal
Gardepanyl
Glysoletten
Gustase-Plus
Haplopan
Haplos
Helional
Hennoletten
Henotal
HMS503E15
HSDB 3157
Hypnaletten
Hypnette
Hypnogen
Hypnolone
Hypnoltol
Hypno-Tablinetten
Hysteps
I06-0652
IDI1_000987
InChI=1/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17
KBio1_000987
le phebar
Lefebar
Leonal
Lephebar
Lepinal
|
Lepinaletten
Levsin PB Drops and Tablets
Linasen
Liquital
Lixophen
LS-135
Lubergal
Lubrokal
Lumen
Lumesettes
Lumesyn
Luminal
Luminal (TN)
Lumofridetten
Luphenil
Luramin
MLS001240232
Molinal
MolPort-001-783-066
MolPort-003-959-166
Monosodium salt phenobarbital
NCGC00159493-02
NCGC00159493-03
Neurobarb
NINDS_000987
Nirvonal
Noptil
Nova-Pheno
NSC 128143
NSC128143
NSC9848
Nunol
Oprea1_384816
P1636_SIGMA
Pamine PB
Parkotal
Pharmetten
Phazyme-PB
Phenaemal
Phen-Bar
Phenemal
Phenemalum
Phenobal
Phenobarb
phenobarbital
Phenobarbital
Phenobarbital (JP15/USP/INN)
phenobarbital (PB)
Phenobarbital [USAN:INN:JAN]
Phenobarbital sodium
Phenobarbital, monosodium salt
Phenobarbital, Monosodium Salt
Phenobarbitalum
Phenobarbitalum [INN]
Phenobarbitalum [INN-Latin]
Phenobarbitate
Phenobarbitic acid
Phenobarbitol
phenobarbitone
Phenobarbitone
Phenobarbitonum
Phenobarbituric acid
Phenobarbituric Acid
Phenobarbyl
Phenoluric
Phenolurio
Phenomet
Phenonyl
Phenoturic
Phenylaethylbarbitursaeure
Phenyläthylbarbitursäure
Phenylbarbital
Phenylethyl barbituric acid
Phenylethylbarbitate
Phenylethylbarbitic acid
Phenylethylbarbiturate
Phenylethylbarbituric acid
Phenyl-ethyl-barbituric acid
Phenylethylbarbituric Acid
Phenylethylbarbitursaeure
Phenylethylbarbitursäure
Phenylethylmalonylurea
PHENYLETHYLMALONYLUREA
Phenyletten
phenylral
Phenyral
Phob
PHOB
Polcominal
Promptonal
PUBERTAL PHENOBARBITAL STUDY
Sedabar
seda-tabl inen
Seda-Tablinen
Sedicat
Sedizorin
Sedlyn
Sedofen
Sedonal
Sedonal (sedative)
Sedonettes
Sedophen
Sevenal
Sinoratox
SK-Phenobarbital
SMR000058986
Sodium, phenobarbital
Solfoton
Solfoton talpheno
Solfoton Talpheno
Solu-Barb
Sombutol
Somnolens
Somnoletten
Somnosan
Somonal
Spasepilin
Starifen
Starilettae
Stental
stental exte ntabs
Stental Extentabs
Talpheno
Teolaxin
Teoloxin
Thenobarbital
Theoloxin
theominal
Triabarb
Tridezibarbitur
Triphenatol
UNII-YQE403BP4D
Valprin 50-PB
Versomnal
WLN: T6VMVMV FHJ F2 FR
Zadoletten
Zadonal
|
|
10 |
|
Acetazolamide |
Approved, Vet_approved |
Phase 4 |
|
59-66-5 |
1986 |
Synonyms:
1424-27-7 (mono-hydrochloride salt)
1yda
1ydb
1ydd
1zsb
2-acetylamino-1,3,4-thiadiazole-5-sulfonamide
2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide
2-acetylamino-1,3,4-Thiadiazole-5-sulphonamide
2h4n
3czv
4-Diamox
5661-25-6
59-66-5
5-acetamido-1,3,4-thiadiazole-2-sulfonamide
5-acetamido-1,3,4-THIADIAZOLE-2-sulfonamide
5-acetamido-1,3,4-THIADIAZOLE-2-sulphonamide
5-acetylamino-1,3,4-thiadiazole-2-sulfonamide
5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide
5-acetylamino-1,3,4-Thiadiazole-2-sulphonamide
8017-69-4
A 6011
A6011_SIAL
A6011_SIGMA
AB00051906
AC-12779
AC1L1CO5
Acetadiazol
Acetamidothiadiazolesulfonamide
Acetamox
Acetazolam
Acetazolamid
Acetazolamida
Acetazolamida [INN-Spanish]
acetazolamide
Acetazolamide
Acétazolamide
Acetazolamide (AAZ)
Acetazolamide (JP15/USP/INN)
Acetazolamide [INN:BAN:JAN]
Acetazolamide apotex brand
Acetazolamide Apotex Brand
Acetazolamide chiesi brand
Acetazolamide Chiesi Brand
Acetazolamide dioptic brand
Acetazolamide Dioptic Brand
Acetazolamide grin brand
Acetazolamide Grin Brand
Acetazolamide icn brand
Acetazolamide ICN Brand
Acetazolamide jumer brand
Acetazolamide Jumer Brand
Acetazolamide llorens brand
Acetazolamide Llorens Brand
Acetazolamide medphano brand
Acetazolamide Medphano Brand
Acetazolamide novopharm brand
Acetazolamide Novopharm Brand
Acetazolamide orion brand
Acetazolamide Orion Brand
Acetazolamide Sodium
Acetazolamide sodium, (sterile)
Acetazolamide Sodium, (Sterile)
Acetazolamide wassermann brand
Acetazolamide Wassermann Brand
Acetazolamide, monosodium salt
Acetazolamide, Monosodium Salt
Acetazolamidum
Acetazolamidum [INN-Latin]
Acetazolamine
Acetazoleamide
Acetozalamide
AI3-52458
Ak zol
Ak Zol
AKOS000715163
Ak-zol
AkZol
Ak-Zol
apo Acetazolamide
Apo Acetazolamide
apo-Acetazolamide
ApoAcetazolamide
Apo-Acetazolamide
Apotex brand OF acetazolamide
Apotex Brand of Acetazolamide
Atenezol
BAS 01585728
BIDD:GT0643
BPBio1_000007
BSPBio_000005
BSPBio_001788
C06805
C4H6N4O3S2
Carbonic anhydrase inhibitor 6063
Carbonic Anhydrase Inhibitor 6063
Carbonic Anhydrase Inhibitor No. 6063
CAS-59-66-5
CCRIS 5811
CHEBI:27690
CHEMBL20
Chiesi brand OF acetazolamide
Chiesi Brand of Acetazolamide
Ciba vision brand OF acetazolamide
Ciba Vision Brand of Acetazolamide
CID1986
Cidamex
CPD000058394
CPD0-1626
Cyanamid brand OF acetazolamide preparation
D000086
D00218
Dazamide
DB00819
Defiltran
Défiltran
Dehydratin
Diacarb
Diakarb
Diamox
|
Diamox (TN)
Diamox Sequels
Didoc
Diluran
Dioptic brand OF acetazolamide
Dioptic Brand of Acetazolamide
Diuramid
Diuramide
Diureticum-holzinger
Diureticum-Holzinger
Diuriwas
Diutazol
DivK1c_000017
Donmox
Duiramid
Edemox
EINECS 200-440-5
EU-0100039
Eumicton
Fonurit
Glauconox
Glaumox
Glaupax
Glupax
Grin brand OF acetazolamide
Grin Brand of Acetazolamide
HMS1568A07
HMS1920A05
HMS2091G05
HMS500A19
HSDB 3002
Huma zolamide
Huma Zolamide
Huma-zolamide
HumaZolamide
Huma-Zolamide
I09-0425
ICN brand OF acetazolamide
ICN Brand of Acetazolamide
IDI1_000017
Jumer brand OF acetazolamide
Jumer Brand of Acetazolamide
KBio1_000017
KBio2_000358
KBio2_002926
KBio2_005494
KBio3_001288
KBioGR_000558
KBioSS_000358
Lederle brand OF acetazolamide preparation
Llorens brand OF acetazolamide
Llorens Brand of Acetazolamide
Lopac0_000039
Lopac-A-6011
LS-10227
medphano Brand OF acetazolamide
Medphano Brand of Acetazolamide
MLS000028435
MLS001148438
MolPort-001-783-578
Monosodium salt acetazolamide
Monosodium Salt Acetazolamide
N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
N-[5-(Aminosulphonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(Aminosulphonyl)-1,3,5-thiadiazol-2-yl]acetamide
Natrionex
NCGC00015074-01
NCGC00015074-02
NCGC00015074-03
NCGC00015074-06
NCGC00015074-11
NCGC00023455-03
NCGC00023455-04
NCGC00023455-05
NCGC00023455-06
NCGC00023455-07
Nephramid
Nephramide
NINDS_000017
Novopharm brand OF acetazolamide
Novopharm Brand of Acetazolamide
NSC 145177
NSC145177
Orion brand OF acetazolamide
Orion Brand of Acetazolamide
Phonurit
Prestwick_4
Prestwick0_000003
Prestwick1_000003
Prestwick2_000003
Prestwick3_000003
SAM002554883
SBB056640
Sk-Acetazolamide
SK-acetazolamide
SMR000058394
SPBio_000004
SPBio_001926
Spectrum_000018
SPECTRUM1500102
Spectrum2_000082
Spectrum3_000284
Spectrum4_000139
Spectrum5_000738
Storz brand OF acetazolamide preparation
Storz Brand of Acetazolamide Preparation
Storzolamide
Théraplix brand OF acetazolamide preparation
UNII-O3FX965V0I
Vetamox
Wassermann brand OF acetazolamide
Wassermann Brand of Acetazolamide
Whelehan brand OF acetazolamide preparation
WLN: T5NN DSJ CSZW EMV1
Wyeth brand OF acetazolamide preparation
Wyeth Brand of Acetazolamide Preparation
|
|
11 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-3-Isobutyl GABA
(S+)-3-isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-isobutyl GABA
3-Isobutyl gaba
3-Isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
|
CI-1008
CID5486971
D02716
DB00230
FT-0080911
GABA, 3-isobutyl
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregabalina
Pregablin
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
|
|
12 |
|
Clonazepam |
Approved, Illicit |
Phase 4 |
|
1622-61-3 |
2802 |
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-nitro-5-(2-Chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-chloro-Phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
Chlonazepam
CID2802
Cloazepam
clonazepam
Clonazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
|
DB01068
DEA No. 2737
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
Landsen
Lktorivil
Lonazep
LS-34156
LS-34260
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4023
Ro 4-8180
Ro 54023
Ro 5-4023
Ro 5-4023/B-7
RO4023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
|
|
13 |
|
Levetiracetam |
Approved |
Phase 4 |
|
102767-28-2 |
441341 |
Synonyms:
(-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
(2S)-2-(2-oxopyrrolidin-1-yl)butanamide
(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
102767-28-2
AC-1479
AC1NR4PY
alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
BIDD:GT0242
C8H14N2O2
CHEMBL1286
CID5284583
CPD000466303
e Keppra
Etiracetam
Etiracetam levo-isomer
Etiracetam, R-isomer
etiracetam, S-isomer
Etiracetam, S-isomer
FT-0082600
HMS2051D07
HMS2089L20
Keppra
Keppra XR
Keppra, Keppra XR),Levetiracetam
L-059
levetiracetam
Levetiracetam
Levetiracetam [INN]
|
Levetiracetame
Levetiracetamum
Levetiracetamum [INN-Latin]
Levetiractam
Leviteracetam
Levitiracetam
LS-137054
MLS000759403
MLS001424069
MolPort-003-848-377
NCGC00186028-01
S1356_Selleck
SAM001246539
SBB070161
SIB-S1
SMR000466303
TL8000131
Torleva
UCB brand OF levetiracetam
Ucb L059
ucb L060
Ucb L060
UCB-22059
UCB-L 059
Ucb-L059
UCB-L059
Ucb-L060
ZINC01547851
|
|
14 |
|
Nitrazepam |
Approved |
Phase 4 |
|
146-22-5 |
4506 |
Synonyms:
1, 3-dihydro-7-nitro-5-Phenyl-2H-1,4-benzodiazepin-2-one
1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
1,3-dihydro-7-nitro-5-Phenyl-2H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
146-22-5
2,3-dihydro-7-nitro-5-Phenyl-1H-1,4-benzodiazepin-2-ON
2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-on
2,3-dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one
2,3-dihydro-7-nitro-5-Phenyl-1H-1,4-benzodiazepin-2-one
5-24-04-00344 (Beilstein Handbook Reference)
7-nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-nitro-1,3-dihydro-5-Phenyl-2H-1,4-benzodiazepin-2-one
7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one
7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
7-nitro-5-Phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-nitro-5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
AC1L1IBJ
AC1Q1XWD
AC-4537
AKOS002254707
Aliud brand OF nitrazepam
Aliud Brand of Nitrazepam
Allphar brand OF nitrazepam
Allphar Brand of Nitrazepam
Alodorm
Alphapharma brand OF nitrazepam
Alphapharma Brand of Nitrazepam
Alpharma brand OF nitrazepam
Alpharma Brand of Nitrazepam
Alter brand OF nitrazepam
Alter Brand of Nitrazepam
Apodorm
Apo-nitrazepam tablets BP
Atempol
Benzalin
Benzalin (TN)
Bio-0690
BRN 0757185
C07487
C15H11N3O3
Calsamin
Calsmin
CCRIS 1931
Cerson
CHEBI:111745
CHEMBL13209
ChemDiv1_022312
CID4506
CPD000058302
CSP Brand of Nitrazepam
CSP Brand OF nitrazepam
ct-Arzneimittel Brand of Nitrazepam
CT-Arzneimittel brand OF nitrazepam
D00531
D009567
DB01595
DDSA brand OF nitrazepam
DDSA Brand of Nitrazepam
DEA No. 2834
Dermatech brand OF nitrazepam
Dermatech Brand of Nitrazepam
Desitin brand OF nitrazepam
Desitin Brand of Nitrazepam
Dormalon
Dormicum
Dormicum (anticonvulsant)
Dormicum brand OF nitrazepam
Dormicum Brand of Nitrazepam
Dormin-5
dormo-Puren
Dormo-Puren
Dumolid
Eatan
Eatan N
EINECS 205-665-2
Epibenzalin
Epinelbon
Eunoctin
Eunoktin
Gerson
Hipnax
Hipsal
HMS2051F19
HMS650G04
I06-0805
Ibrovek
ICN brand OF nitrazepam
ICN Brand of Nitrazepam
Imadorm
Imeson
Imesont
InChI=1/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)
Ipersed
ISOPROPYLACETATE/NITRAZEPAM
|
LA 1
LA 1 (VAN)
LS-34311
Magadon
Megadon
Mitidin
MLS001304053
Mogadan
Mogadon
Mogadone
MolPort-000-302-259
MolPort-000-699-491
N3889_SIGMA
NCGC00159358-02
nchembio747-comp31
N-desmethylnimetazepam
N-Desmethylnimetazepam
Nelbon
Nelmat
Neozepam
Neuchlonic
neuraxpharm Brand of Nitrazepam
Neuraxpharm brand OF nitrazepam
Nitrados
Nitravet
Nitrazadon
Nitrazep
nitrazepam
Nitrazepam
Nitrazépam
Nitrazepam (JP15/USAN/INN)
Nitrazepam (TN)
Nitrazepam [USAN:INN:BAN:JAN]
Nitrazepam al
Nitrazepam AL
Nitrazepam-10
Nitrazepam-5
Nitrazepam-neuraxpharm
Nitrazepamum
Nitrazepamum [INN-Latin]
Nitrempax
Nitrenpax
Nitrodiazepam
Noctesed
Norgine brand OF nitrazepam
Norgine Brand of Nitrazepam
Novanox
NSC 58775
NSC58775
NSC-58775
Oprea1_476234
Pacisyn
Paxisyn
PDSP1_000120
PDSP2_000120
Pelson
Persopit
Pfleger brand OF nitrazepam
Pfleger Brand of Nitrazepam
Protea brand OF nitrazepam
Protea Brand of Nitrazepam
Radedorm
Relact
Remnos
Rhoxal-nitrazepam
Rhoxalpharma brand OF nitrazepam
Rhoxalpharma Brand of Nitrazepam
ro 4-5360
Ro 4-5360
ro 5-3059
Ro 5-3059
Ro 53-60
S 2000
SAM001246711
Sandoz nitrazepam
Scheurich brand OF nitrazepam
Scheurich Brand of Nitrazepam
Serenade
SMR000058302
Somitran
Somnased
Somnibel
Somnite
Sonebon
Sonebon Tofraniln A
Sonnolin
STK806322
Surem
Taurus brand OF nitrazepam
Taurus Brand of Nitrazepam
Trazenin
Unisomnia
United drug brand OF nitrazepam
United Drug Brand of Nitrazepam
Wernigerode brand OF nitrazepam
Wernigerode Brand of Nitrazepam
WLN: T67 GMV JN IHJ CNW KR
ZINC04311748
|
|
15 |
|
Gabapentin |
Approved, Investigational |
Phase 4 |
|
60142-96-3 |
3446 |
Synonyms:
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
1-(Aminomethyl)-cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
Aclonium
AKOS000280865
apo-Gabapentin
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
Convalis
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G0318
G-154
G154_SIGMA
Gabapen
gabapentin
Gabapentin
Gabapentin (JAN/USAN/INN)
gabapentin (Neurontin)
Gabapentin [USAN:INN:BAN]
Gabapentin GR
Gabapentin hexal
Gabapentin Hexal
Gabapentin stada
Gabapentin Stada
gabapentina
Gabapentina
Gabapentine
Gabapentine [INN-French]
gabapentinium
Gabapentino
|
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GBN
Go 3450
GOE 2450
Goe-3450
Hexal brand of gabapentin
HMS1570N03
HMS2089J03
HSDB 7364
I06-0677
L000733
Lopac0_000582
Lopac-G-154
LS-7194
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
Neurontin
Neurontin (TN)
novo-Gabapentin
Novo-Gabapentin
novo-Gabapentine
Novopharm brand of gabapentin
NSC742194
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
PMS-Gabapentin
Prestwick_151
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
ratiopharm brand of gabapentin
S2133_Selleck
Serada
SMR000058311
SPBio_002822
Stadapharm brand of gabapentin
STK598009
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
|
|
16 |
|
Tiagabine |
Approved, Investigational |
Phase 4 |
|
115103-54-3 |
60648 |
Synonyms:
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotate
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate
(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
(R)-(-)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate
(R)-(-)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
(R)-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride
(R)-Tiagabine
115103-54-3
A-70569-1
ABBOTT-70569-1
AC1L1TNE
AC1Q5R43
AC-7048
BIDD:GT0018
C07503
C20H25NO2S2
CHEBI:222170
CHEMBL1027
CID60648
D08588
|
DB00906
Gabitril
Gabitril (TN)
HSDB 7527
LS-114651
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
N-(4,4-Di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
NCGC00164626-01
NO 329
NO-328
NO-329
Tiagabina
Tiagabina [INN-Spanish]
tiagabine
Tiagabine
Tiagabine (INN)
Tiagabine [INN:BAN]
Tiagabine [INN]
Tiagabine, (S)-isomer
Tiagabinum
Tiagabinum [INN-Latin]
UNII-Z80I64HMNP
|
|
17 |
|
Felbamate |
Approved |
Phase 4 |
|
25451-15-4 |
3331 |
Synonyms:
(3-carbamoyloxy-2-phenylpropyl) carbamate
(3-carbamoyloxy-2-phenyl-propyl) carbamate
1,3-Propanediol, 2-phenyl-, dicarbamate
25451-15-4
2-phenyl-1,3-propanediol dicarbamate
2-Phenyl-1,3-propanediol dicarbamate
2-Phenyl-1,3-propanediol dicarbamic acid
2-Phenylpropane-1,3-diyl dicarbamate
4-06-00-05993 (Beilstein Handbook Reference)
AC1L1FOW
ADD-03055
BIDD:GT0463
Biomol-NT_000203
BPBio1_001258
BRD-K99107520-001-01-9
BRN 3345236
C047360
C07501
C11H14N2O4
Carbamate 2-phenyltrimethylene ester
Carbamate 3-carbamoyloxy-2-phenyl-propyl ester
carbamic acid 2-phenyltrimethylene ester
Carbamic acid 2-phenyltrimethylene ester
Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester
Carbamic acid, 2-phenyltrimethylene ester
CHEBI:4995
CHEMBL1094
CID3331
D00536
DB00949
EINECS 247-001-4
Essex brand of felbamate
EU-0100524
F 0778
F0778_SIGMA
felbamate
Felbamate
Felbamate (USAN/INN)
Felbamate [USAN:INN]
Felbamato
Felbamato [Spanish]
|
Felbamatum
Felbamatum [Latin]
Felbamic acid
Felbamyl
Felbatol
Felbatol (TN)
HMS2093P19
HSDB 7525
I06-0353
Lopac0_000524
Lopac-F-0778
LS-120706
MLS000028465
MLS000758238
MLS001077299
MolPort-003-666-873
NCGC00015429-01
NCGC00015429-02
NCGC00015429-06
NCGC00015429-09
NCGC00023092-02
NCGC00023092-04
NCGC00023092-05
NCGC00023092-06
Prestwick0_000919
S1330_Selleck
SBB070639
Schering brand of felbamate
Schering-Plough brand of felbamate
SMR000058448
SMR000449307
Taloxa
Tocris-0869
UNII-X72RBB02N8
W 554
W-554
Wallace brand 1 of felbamate
Wallace brand 1 OF felbamate
Wallace brand 2 of felbamate
Wallace brand 2 OF felbamate
ZINC01530803
|
|
18 |
|
Phenytoin |
Approved, Vet_approved |
Phase 4 |
|
57-41-0 |
1775 |
Synonyms:
125-59-7
2,4-Imidazolidinedione, 5,5-diphenyl- (9CI)
2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one
5,5-Diphenyl-2,4-imidazolidinedione
5,5-diphenylhydantoin
5,5-Diphenylhydantoin
5,5-DIPHENYLHYDANTOIN
5,5-Diphenylhydantoin (IUPAC)
5,5-Diphenylhydantoin (phenytoin)
5,5-Diphenylimidazolidin-2,4-dione
5,5-diphenylimidazolidine-2,4-dione
5,5-Diphenylimidazolidine-2,4-dione
5,5-Diphenyl-imidazolidine-2,4-dione
5,5-diphenyltetrahydro-1H-2,4-imidazoledione
5,5-diphenyltetrahydro-1H-2,4-Imidazoledione
5,5-Diphenyltetrahydro-1H-2,4-imidazoledione
5,5-Dwufenylohydantoina
5,5-Dwufenylohydantoina [Polish]
57-41-0
630-93-3
AC1L1C7L
AC1Q6G55
AC1Q6G56
AC-376
AI3-52498
AKOS000416887
AKOS003245432
Aleviatin
Antisacer
Auranile
BAS 00281572
BIDD:GT0625
BIDD:PXR0090
Bio-0370
BRD-K55930204-001-02-7
BSPBio_001437
C07443
Causoin
CCRIS 515
CHEBI:8107
CHEMBL16
CID1775
Citrullamon
Citrulliamon
CL12003
Comital
Comitoina
component of Mebroin
Convul
D 4007
D00512
D0894
D4007_SIGMA
Danten
Dantinal
Dantoinal
Dantoinal klinos
Dantoine
DB00252
Denyl
Didan TDC 250
Didan-tdc-250
Difenilhidantoina
Difenilhidantoina [Spanish]
Difenin
Difetoin
Difhydan
Dihycon
Dihydan
Di-Hydan
Dihydan toin
Dihydantoin
Dilabid
Di-Lan
Di-Lan (VAN)
Dilantin
DILANTIN
Dilantin (TN)
Dilantin acid
Dilantin-125
DILANTIN-30
Dilantine
Dillantin
Dintoin
Dintoina
Diphantoin
Diphedal
Diphedan
Diphenat
Diphenin
Diphenine
Diphentoin
Diphentyn
Diphenylan
Diphenylan sodium
Diphenylan Sodium
Diphenylhydantoin
Diphenylhydantoin (VAN)
Diphenylhydantoinate, sodium
Diphenylhydantoine
Diphenylhydantoine [French]
Diphenylhydatanoin
Di-Phetine
Ditoinate
DivK1c_000507
DPH
DPH (VAN)
EINECS 200-328-6
Ekko
Ekko capsules
elepsi ndon
Elepsindon
Enkelfel
Epamin
Epanutin
Epasmir "5"
epasmir ''5''
Epasmir 5
Epdantoin Simple
Epdantoine simple
Epelin
Epifenyl
Epihydan
Epilan
Epilan D
Epilan-D
Epilantin
Epinat
Epised
Eptal
Eptoin
EU-0100378
Extended Phenytoin Sodium
fen toin
Fenantoin
Fenantoin Mn Pharma
Fenidantoin "s"
fenidantoin ''s''
Fenidantoin s
Fenitoin
Fenitoina
Fenitoina [INN-Spanish]
Fentoin
Fenylepsin
Fenytoin Dak
Fenytoine
|
Gerot-epilan-D
Hidan
Hidantal
Hidantilo
Hidantina
Hidantina senosian
Hidantina vitoria
Hidantomin
Hindatal
HMS1412J16
HMS1694O05
HMS1791H19
HMS1989H19
HMS2089E11
Hydantal
Hydantin
Hydantoin
Hydantoin, 5,5-diphenyl- (8CI)
Hydantoinal
Hydantol
I14-6452
ictalis simp le
Ictalis simple
Idantoil
Idantoin
IDI1_000507
IDI1_008433
IFLab1_000214
InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19
Iphenylhydantoin
KBio1_000507
KBio2_001585
KBio2_004153
KBio2_006721
KBio3_001780
KBioGR_001387
KBioSS_001585
Kessodanten
Labopal
Lehydan
Lepitoin
Lepsin
Lopac0_000329
Lopac0_000378
Lopac-D-4007
LS-34
Mesantoin
Minetoin
MLS000069789
MLS001074087
MLS002454401
MolPort-001-785-683
MolPort-002-365-712
MolPort-004-876-351
NCGC00015342-01
NCGC00015342-02
NCGC00015342-04
NCGC00021139-01
NCGC00091492-01
NCGC00091492-02
NCGC00091492-03
NCGC00091492-04
NCGC00091492-05
NCGC00093810-01
NCGC00093810-02
NCI-C55765
Neos-Hidantoina
Neosidantoina
NINDS_000507
Novantoina
Novophenytoin
NSC 8722
NSC8722
Om hidantoina simple
Om-Hydantoine
Oprea1_373280
Oxylan
Park davis brand OF phenytoin
Pfizer brand OF phenytoin
Phanantin
Phanatine
phenat ine
Phenatine
Phenatoine
Phenhydan
Phenhydanin
Phenitoin
Phentoin
Phentytoin
PHENTYTOIN
PHENYTEK
Phenytex
phenytoin
Phenytoin
PHENYTOIN (5,5-DIPHENYLHYDANTOIN)
Phenytoin (JP15/USP/INN)
phenytoin (PHN)
Phenytoin [USAN:INN:BAN:JAN]
Phenytoin AWD
Phenytoin pfizer brand
Phenytoin phizer brand
Phenytoin sodium
Phenytoin Sodium
PHENYTOIN SODIUM, EXTENDED
Phenytoine
Phenytoine [INN-French]
Phenytoin-Gerot
Phenytoinum
Phenytoinum [INN-Latin]
Phizer brand OF phenytoin
Prompt Phenytoin Sodium
Ritmenal
Saceril
Sanepil
Silantin
Sinergina
SMR000059026
Sodanthon
Sodantoin
Sodanton
Sodium diphenylhydantoinate
Sodium Diphenylhydantoinate
Solantin
Solantoin
Solantyl
SPBio_001281
Spectrum_001105
Spectrum2_001281
Spectrum3_000890
Spectrum4_000984
Spectrum5_001369
STK058029
STK182871
Sylantoic
taco sal
Tacosal
Thilophenyl
TOIN
Toin unicelles
UNII-6158TKW0C5
WLN: T5MVMV EHJ ER& ER
Zentronal
Zentropil
ZINC02510358
ZINC18140189
|
|
19 |
|
Clobazam |
Approved, Illicit |
Phase 4 |
|
22316-47-8 |
2789 |
Synonyms:
1-phenyl-5-methyl-8-chloro-1,2,4,5- tetrahydro-2,4-diketo-3H-1,5-benzodiazepine
1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3H-1,5-benzodiazepine
1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1, 5-benzodiazepine
1-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine
1-Phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-dioxo-3H-1,5-benzodiazepine
22316-47-8
4(3H,5H)-dione
5-24-08-00034 (Beilstein Handbook Reference)
7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione
7-chloro-1-Methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione
7-Chloro-1-methyl-5-phenyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione
7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,
7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione
7-Chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4-(3H,5H)-dione
AC1L1EGZ
AC-273
Ambap22316-47-8
BRN 0758410
C012255
C8414_SIGMA
Caastilium
CCRIS 7506
CHEBI:31413
CHEMBL70418
Chlorepin
CID2789
clobazam
Clobazam
Clobazam (JAN/USAN/INN)
Clobazam [USAN:BAN:INN]
Clobazamum
|
Clobazamum [INN-Latin]
Clorepin
D01253
DB00349
DEA No. 2751
EINECS 244-908-7
Frisium
H 4723
H-4723
HR 376
LM 2717
LM-2717
LS-34098
MolPort-003-940-848
Mystan
Mystan (TN)
NCGC00168249-01
nchembio747-comp39
Noiafren
NSC 336279
NSC336279
Odipam
Onfi
RU-4723
UNII-2MRO291B4U
Urbadan
Urbanil
Urbanyl
WLN: T67 GNV JVN IHJ CG G1 KR
ZINC00001175
|
|
20 |
|
Oxcarbazepine |
Approved |
Phase 4 |
|
28721-07-5 |
34312 |
Synonyms:
10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide
10,11-dihydro-10-oxo-5H-Dibenz(b,F)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
28721-07-5
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
AB1004555
AC1L1RCU
AC1Q6NA8
AC-3483
BIDD:GT0078
Bio-0527
BSPBio_003457
C036006
C07492
CHEMBL1068
CID34312
CPD000048684
D00533
DB00776
Desitin brand of oxcarbazepine
Desitin brand OF oxcarbazepine
EINECS 249-188-8
Epilexter
Epliga
GP 47680
GP-47680
HMS1922H17
HMS2051O04
HMS2090F13
HMS2093E10
HSDB 7524
I06-0072
KBio2_002155
KBio2_004723
KBio2_007291
KBio3_002677
KBioGR_001248
KBioSS_002155
KIN-493
|
LS-60365
MLS000084586
MLS000759520
MLS001201742
MolPort-001-685-316
NCGC00065934-02
NCGC00065934-03
NCGC00065934-04
Novartis brand of oxcarbazepine
Novartis brand OF oxcarbazepine
O0363
O3764_SIGMA
OCBZ
Oxacarbazepine
Oxcarbamazepine
Oxcarbazepime
Oxcarbazepina
Oxcarbazepina [INN-Spanish]
oxcarbazepine
Oxcarbazepine
OXCARBAZEPINE
Oxcarbazepine (USAN/INN)
Oxcarbazepine [INN]
Oxcarbazepinum
Oxcarbazepinum [INN-Latin]
S1391_Selleck
SAM001246754
SMR000048684
SPBio_000345
Spectrum_001675
SPECTRUM1504243
Spectrum2_000483
Spectrum3_001669
Spectrum4_000634
Spectrum5_001869
SPN-804
STK594696
Timox
Trileptal
Trileptal (TN)
UNII-VZI5B1W380
ZINC00004724
|
|
21 |
|
Vigabatrin |
Approved |
Phase 4 |
|
68506-86-5, 60643-86-9 |
5665 |
Synonyms:
( inverted question mark)-gamma-Vinyl GABA
(?)-gamma-Vinyl GABA
(R,S)-4-Amino-5-hexenoic acid
.gamma.-Vinyl-.gamma.-aminobutyric acid
.gamma.-Vinyl-GABA
4-amino-5-Hexenoate
4-amino-5-Hexenoic acid
4-Amino-5-hexenoic acid
4-aminohex-5-enoic acid
4-Aminohexenoic acid
60643-86-9
74046-07-4
AB00053309
AC1L1KUZ
Acid, gamma-vinyl-gamma-aminobutyric
Acid, gamma-Vinyl-gamma-Aminobutyric
Aventis brand OF vigabatrin
Aventis Brand of Vigabatrin
Biomol-NT_000247
BPBio1_000465
BPBio1_000925
BSPBio_000421
BSPBio_003469
C07500
C6H11NO2
CHEBI:241484
CHEMBL89598
CID5665
CPP-109
D00535
D020888
DB01080
DivK1c_006760
EU-0101277
gamma Vinyl gaba
gamma Vinyl GABA
Gamma vinyl GABA
gamma Vinyl gamma aminobutyric acid
gamma Vinyl gamma Aminobutyric Acid
gamma-Vinyl gaba
gamma-Vinyl GABA
gamma-Vinyl-gaba
gamma-Vinyl-GABA
gamma-Vinyl-gamma-aminobutyrate
gamma-Vinyl-gamma-aminobutyric acid
gamma-Vinyl-gamma-Aminobutyric Acid
GVG
g-Vinyl gaba
g-Vinyl-g-aminobutyrate
g-Vinyl-g-aminobutyric acid
Hexenoic acid, 4-amino
HMS1569F03
HMS2094M21
Hoechst brand OF vigabatrin
Hoechst Brand of Vigabatrin
KBio1_001704
KBio2_000848
KBio2_003416
|
KBio2_005984
KBio3_002973
KBioSS_000848
Lopac0_001277
LS-75569
M071754
MDL 71,754
MDL 71754
MDL-71754
MolPort-003-666-796
NCGC00016087-03
NCGC00016087-08
NCGC00024802-02
NCGC00024802-03
NCGC00024802-04
NCGC00024802-05
NCGC00024802-06
Prestwick_837
Prestwick0_000501
Prestwick1_000501
Prestwick2_000501
Prestwick3_000501
RMI 71754
RMI-71754
RMI-71890
Sabril
Sabril (TN)
Sabrilex
SPBio_002342
SpecPlus_000664
Spectrum_000368
SPECTRUM1502036
Spectrum3_001825
V 8261
V8261_SIGMA
vigabatrin
Vigabatrin
Vigabatrin (JAN/USAN/INN)
Vigabatrin [USAN:BAN:INN]
Vigabatrin [USAN:INN:BAN]
Vigabatrin aventis brand
Vigabatrin Aventis Brand
Vigabatrin hoechst brand
Vigabatrin Hoechst Brand
Vigabatrin yamanouchi brand
Vigabatrin Yamanouchi Brand
Vigabatrina
Vigabatrina [Spanish]
Vigabatrine
Vigabatrine [French]
Vigabatrinum
Vigabatrinum [Latin]
Vinyl gamma-aminobutyric acid
Yamanouchi brand OF vigabatrin
Yamanouchi Brand of Vigabatrin
γ-vinyl gaba
γ-vinyl-γ-aminobutyrate
γ-vinyl-γ-aminobutyric acid
|
|
22 |
|
Ethosuximide |
Approved |
Phase 4 |
|
77-67-8 |
3291 |
Synonyms:
(+-)-2-Ethyl-2-methylsuccinimide
(±)-2-ethyl-2-methylsuccinimide
.alpha.-Ethyl-.alpha.-methylsuccinimide
.gamma.-Methyl-.gamma.-ethylsuccinimide
2-ethyl-2-methylsuccinimide
2-Ethyl-2-methylsuccinimide
2-methyl-2-ethylsuccinimide
2-Methyl-2-ethylsuccinimide
3-Ethyl-3-methyl-2, 5-pyrrolidinedion
3-ethyl-3-methyl-2,5-pyrrolidinedione
3-Ethyl-3-methyl-2,5-pyrrolidinedione
3-Ethyl-3-methylpyrrolidine-2,5-dione
3-Ethyl-3-methylpyrroline-2,5-dione
3-ethyl-3-methylsuccinimide
3-Ethyl-3-methylsuccinimide
3-methyl-3-ethylpyrrolidine-2,5-dione
3-Methyl-3-ethylpyrrolidine-2,5-dione
3-methyl-3-ethylsuccinimide
3-Methyl-3-ethylsuccinimide
5-21-09-00595 (Beilstein Handbook Reference)
77-67-8
AB00052288
AC1L1FLN
AC1Q2SOO
Aethosuccimidum
Aethosuximide
Aethosuximide [German]
a-Ethyl-a-methylsuccinimide
alpha-Ethyl-alpha-methylsuccinimide
alpha-Methyl-alpha-ethylsuccinimide
a-Methyl-a-ethylsuccinimide
Asamid
Atysmal
BPBio1_000033
BRD-A99633051-001-04-7
BRN 0117054
BSPBio_000029
C.I. 366
C07505
Capitus
CHEBI:131811
CHEBI:4887
CHEMBL696
CI 366
CI-366
CID3291
Cl 366
CN-10,395
CN-10395
D005013
D00539
DB00593
Desitin brand OF ethosuximide
Desitin Brand of Ethosuximide
DivK1c_000218
e
E 7138
E0746
E7138_SIGMA
EINECS 201-048-7
Emeside
Epileo Petit Mal
Epileo Petit MAL
Ethosuccimid
Ethosuccimide
Ethosuccinimide
Ethosuxide
Ethosuximid
ethosuximide
Ethosuximide
éthosuximide
Ethosuximide (JP15/USP/INN)
Ethosuximide [USAN:INN:BAN:JAN]
Ethosuximidum
Ethosuximidum [INN-Latin]
Ethylmethylsuccimide
Ethymal
Etomal
Etosuccimide
Etosuccimide [DCIT]
Etosuximid
Etosuximida
Etosuximida [INN-Spanish]
Etosuximida faes
Etosuximida Faes
Etosuximide
EU-0100532
Faes brand OF ethosuximide
Faes Brand of Ethosuximide
Faes, etosuximida
Faes, Etosuximida
Fortbenton brand OF ethosuximide
Fortbenton Brand of Ethosuximide
gamma-ethyl-gamma-methyl-succinimide
gamma-Ethyl-gamma-methyl-succinimide
gamma-Methyl-gamma-ethyl-succinimide
g-Ethyl-g-methyl-succinimide
g-Methyl-g-ethyl-succinimide
H 940
|
H-490
HMS1568B11
HMS1921L14
HMS2092D20
HMS500K20
HSDB 1119
IDI1_000218
Jenapharm brand OF ethosuximide
Jenapharm Brand of Ethosuximide
Katwijk brand OF ethosuximide
Katwijk Brand of Ethosuximide
KBio1_000218
KBio2_001865
KBio2_004433
KBio2_007001
KBio3_002008
KBioGR_001342
KBioSS_001865
LAB brand OF ethosuximide
LAB Brand of Ethosuximide
Lopac0_000532
LS-147585
Mesentol
MolPort-003-666-417
NCGC00015418-02
NCGC00015418-06
NCGC00093923-01
NCGC00093923-02
NCGC00093923-03
NCGC00093923-04
NCIOpen2_000014
N-Ethyl methylsuccinimide
NINDS_000218
NSC 64013
NSC64013
Parke davis brand OF ethosuximide
Parke Davis Brand of Ethosuximide
Pemal
Pemalin
Pentinimid
Peptinimid
Petinimid
Petnidan
Pfizer brand OF ethosuximide
Pfizer Brand of Ethosuximide
Piknole.psi.n
Piknolepsin
PM 671
PM-671
Prestwick_611
Prestwick0_000165
Prestwick1_000165
Prestwick2_000165
Prestwick3_000165
Pyknole.psi.num
Pyknolepsinum
Ronton
Simatin
Simatin(E)
SPBio_001465
SPBio_001950
Spectrum_001385
SPECTRUM1502196
Spectrum2_001483
Spectrum3_000944
Spectrum4_001051
Spectrum5_001073
ST51037248
Succimal
Succimitin
Suksilep
Suxilep
Suximal
Suxin
Suxinutin
Thetamid
Thilopemal
UNII-5SEH9X1D1D
United drug brand OF ethosuximide
United Drug Brand of Ethosuximide
Warner lambert brand OF ethosuximide
Warner Lambert Brand of Ethosuximide
Warner-lambert brand OF ethosuximide
Warner-Lambert Brand of Ethosuximide
Wernigerode brand OF ethosuximide
Wernigerode Brand of Ethosuximide
WLN: T5VMVTJ D2 D1
Zaraondan
Zarodan
Zarondan
Zarondan-Saft
Zarontin
Zarontin (TN)
Zartalin
α-ethyl-α-methylsuccinimide
α-methyl-α-ethylsuccinimide
γ-ethyl-γ-methyl-succinimide
γ-methyl-γ-ethyl-succinimide
|
|
23 |
|
Carbamazepine |
Approved, Investigational |
Phase 4 |
|
298-46-4 |
2554 |
Synonyms:
298-46-4
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz(b,F)azepine
5-carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
benzo[b][1]benzazepine-11-carboxamide
BIDD:GT0479
BIM-0050280.0001
Bio-0751
Bipotrol
Biston
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
carbamazepine
Carbamazepine
Carbamazépine
Carbamazepine (JP15/USP/INN)
carbamazepine (Tegretol)
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepine acetate
Carbamazepine anhydrous
Carbamazepine dihydrate
Carbamazepine hydrochloride
Carbamazepine L-tartrate (4:1)
Carbamazepine phosphate
Carbamazepine sulfate (2:1)
CARBAMAZEPINE, U.S.P.
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
ChemDiv1_018966
CID2554
CPD001227191
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
|
Equetro (TN)
EU-0100292
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
Karbamazepin
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Lexin
Lopac0_000292
Lopac-C-4024
LS-60362
MLS000069652
MLS001055475
MLS001074172
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
nchem.859-comp7
Neurotol
Neurotop retard
NINDS_000388
Novo-Carbamaz
NSC 169864
NSC169864
Nu-Carbamazepine
Oprea1_790775
Prestwick_104
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
S1693_Selleck
SAM002264603
Sirtal
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
Spectrum_000096
SPECTRUM1500159
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Stazepin
Stazepine
STK177357
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
|
|
24 |
|
Valproic acid |
Approved, Investigational |
Phase 4 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 PP (base)
2 Propylpentanoic acid
2-N-Propyl-N-valerate
2-n-propyl-n-valeric acid
2-n-Propyl-n-valeric acid
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-propyl-pentanoic acid
2-Propylpentanoic acid
2-Propylpentanoic Acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-propylvaleric acid
2-Propylvaleric acid
2-Propylvaleric Acid
4-Heptanecarboxylate
4-heptanecarboxylic acid
4-Heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
Abbott 44090
AC1L1F7T
AC1Q2ULA
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acide valproique [INN-French]
acido Valproico
Acido valproico
ácido valproico
Acido valproico [INN-Spanish]
acidum valproicum
Acidum valproicum
Acidum valproicum [INN-Latin]
AI3-10500
Alti-valproic
Alti-Valproic
apo-Divalproex
apo-Valproic
apo-Valproic syrup
Avugane
Baceca
BIDD:GT0858
BRN 1750447
C07185
Calcium valproate
Calcium, valproate
CHEBI:39867
CHEMBL109
CID3121
Convulex
Convulsofin
CPD000499581
D00399
DB00313
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetate
di-n-propylacetic acid
Di-n-propylacetic acid
Di-N-propylacetic acid
Di-n-propylessigsaeure
Di-N-propylessigsaeure
Di-n-propylessigsaure
Di-N-propylessigsaure
Di-n-propylessigsäure
Di-n-propylessigsaure [German]
Dipropyl acetate
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DivK1c_000273
DOM-divalproex
Dom-valproate
Dom-Valproic
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
EINECS 202-777-3
Epiject i.v.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
|
KBio2_004845
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
Magnesium valproate
Med valproic
Med Valproic
MLS001076682
MLS001335927
MLS001335928
MLS002415770
MolPort-001-791-895
Mylproin
Myproate
Myproic acid
Myproic Acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
nchembio.79-comp4
nchembio815-comp21
n-Dipropylacetic acid
N-Dipropylacetic acid
n-DPA
N-DPA
NINDS_000273
novo-Divalproex
novo-Valproic
Novo-Valproic
novo-Valproic - ecc
novo-Valproic soft gel cap
NSC 93819
NSC93819
Nu-valproic
Nu-Valproic
P0823
P6273_SIGMA
PEAC
Penta-valproic
Penta-Valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic Acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
ratio-Valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
Sandoz valproic
Savicol
SBB065764
Semisodium valproate
Semisodium Valproate
SMR000499581
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
SPBio_000912
Spectrum_000521
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Sprinkle
Stavzor
UNII-614OI1Z5WI
Valcote
Valparin
valproate
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
valproic acid
Valproic acid
VALPROIC ACID
Valproic acid (USP)
Valproic acid [USAN:INN:BAN]
Valproic acid usp
Valproic acid USP
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproic Acid, Sodium Salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
WLN: QVY3 & 3
|
|
25 |
|
Riluzole |
Approved, Investigational |
Phase 4 |
|
1744-22-5 |
5070 |
Synonyms:
1744-22-5
2 amino 6 Trifluoromethoxybenzothiazole
2-amino-6-(trifluoromethoxy)-1,3-benzothiazole
2-amino-6-(trifluoromethoxy)benzo[d]thiazole
2-Amino-6-(trifluoromethoxy)benzothiazole
2-Amino-6-(trifluoromethoxy)-benzothiazole
2-amino-6-(trifluoromethoxyl)benzothiazole
2-Amino-6-trifluoro- methoxybenzothiazole
2-amino-6-trifluoromethoxybenzothiazole
2-amino-6-Trifluoromethoxybenzothiazole
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
6-(trifluoromethoxy)benzo[d]thiazol-2-amine
6-Trifluoromethoxy-benzothiazol-2-ylamine
6-trifluoromethoxybenzothiazole-2-yl-amine
AC1L1JJL
AC1Q530H
AC-730
AKOS000265071
ALBB-006046
Amino-2 trifluoromethoxy-6 benzothiazole
Amino-2 trifluoromethoxy-6 benzothiazole [French]
Aventis behring brand OF riluzole
Aventis brand OF riluzole
BB_SC-4839
BF-37
BIDD:GT0055
Bio1_000416
Bio1_000905
Bio1_001394
Biomol-NT_000245
BPBio1_000037
BPBio1_000837
BRD-K21283037-001-02-5
BRD-K21283037-003-03-9
BSPBio_000033
C07937
C8H5F3N2OS
CHEMBL744
CID5070
D00775
DB00740
EU-0101064
FT-0082997
HMS1773G08
HMS2089O19
HMS2094G07
I01-2084
Impax brand OF riluzole
Lopac0_001064
|
Lopac-R-116
LS-40688
MLS000069369
MolPort-000-151-262
NCGC00015882-01
NCGC00015882-02
NCGC00015882-03
NCGC00015882-07
NCGC00015882-11
NCGC00023141-02
NCGC00023141-04
NCGC00023141-05
NCGC00023141-06
PK-26124
PK-26124, RP-54274, Rilutek, Riluzole
Prestwick0_000167
Prestwick-03A08
Prestwick1_000167
Prestwick2_000167
Prestwick3_000167
R-116
R116_SIGMA
Rhone poulenc rorer brand OF riluzole
Rhone-poulenc rorer brand OF riluzole
Rilutek
Rilutek (TN)
Riluzol
Riluzol [INN-Spanish]
riluzole
Riluzole
Riluzole (JAN/USAN/INN)
Riluzole [USAN:INN]
Riluzole aventis brand
Riluzole HCl
Riluzole impax brand
Riluzolum
Riluzolum [INN-Latin]
RP 54274
RP-54274
S1614_Selleck
SMR000058231
SPBio_000599
SPBio_001954
Spectrum2_000550
STK503686
Tocris-0768
UNII-7LJ087RS6F
ZERO/001785
ZINC00006481
|
|
26 |
|
Levomilnacipran |
Approved, Investigational |
Phase 4 |
|
96847-54-0 |
|
Synonyms:
|
27 |
|
Milnacipran |
Approved, Investigational |
Phase 4 |
|
92623-85-3 |
65833 |
Synonyms:
( -)-Milnacipran
(-)-milnacipran
(-)-Milnacipran
(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide
(+-)-Milnacipran
(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide
105310-09-6
1-phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl
1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCL
92623-85-3
AC1L2425
CHEMBL252923
CID65833
D08222
DB04896
F 2207
F2207
|
F-2207
Ixel
Levomilnacipran
LS-178180
Midalcipran
milnacipran
Milnacipran
Milnacipran (INN)
Milnacipran [INN]
Milnacipran hydrochloride
Milnacipranum
Milnacipranum [latin]
Milnacipranum [Latin]
NCGC00165825-01
Savella
Toledomin
UNII-G56VK1HF36
|
|
28 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(-)-Arterenol free base
(−)-noradrenaline
(-)-Noradrenaline
(-)-NORADRENALINE
(−)-norepinephrine
(-)-Norepinephrine
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-Noradrenaline
(R)-norepinephrine
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-amino-1-Hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
Abbott brand OF levophed bitartrate
AC1L96ZT
Adrenor
Aktamin
ALBB-006229
Arterenol
Aventis brand OF norepinephrine hydrochloride
Bitartrate, levophed
Bitartrate, noradrenaline
Bitartrate, norepinephrine
bmse000404
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
Hydrochloride, norepinephrine
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
L-3,4-dihydroxyphenylethanolamine
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-Arterenol
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
|
Levophed
Levophed bitartrate
L-noradrenaline
L-Noradrenaline
L-Norepinephrine
L-NOREPINEPHRINE
LS-42676
LT03330026
LT4
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
noradrenaline
Noradrenaline
Nor-adrenaline
Noradrenaline (JP15)
Noradrenaline bitartrate
Noradrénaline tartrate renaudin
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
norepinefrina
Norepinefrina
Norepinephrin D-tartrate (1:1)
norepinephrine
Norepinephrine
Norépinéphrine
Norepinephrine (INN)
Norepinephrine [INN:JAN]
Norepinephrine bitartrate
Norepinephrine D-tartrate (1:1)
Norepinephrine hydrochloride
Norepinephrine hydrochloride, (+)-isomer
Norepinephrine hydrochloride, (+,-)-isomer
Norepinephrine l-Tartrate (1:1)
Norepinephrine L-tartrate (1:1)
Norepinephrine L-tartrate (1:1), (+,-)-isomer
Norepinephrine L-tartrate (1:1), monohydrate
Norepinephrine L-tartrate (1:1), monohydrate, (+)-isomer
Norepinephrine L-tartrate (1:2)
Norepinephrine L-tartrate, (+)-isomer
Norepinephrine Noradrenalin
Norepinephrine, (+)-isomer
Norepinephrine, (+,-)-isomer
norepinephrinum
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
Nor-epirenan
PDSP1_001111
PDSP2_001095
Renaudin brand OF norepinephrine bitartrate
Renaudin, noradrénaline tartrate
SGCUT00123
SPBio_001048
Spectrum_001009
SPECTRUM1500436
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
STK503776
Sympathin e
Sympathin E
Tartrate renaudin, noradrénaline
to_000024
UNII-X4W3ENH1CV
|
|
29 |
|
Dopamine |
Approved |
Phase 4 |
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
30 |
|
Lovastatin |
Approved, Investigational |
Phase 4 |
|
75330-75-5 |
53232 |
Synonyms:
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyric acid
1 alpha-Isomer lovastatin
1cqp
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinate lactone
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinate lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinate lactone
2β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinic acid lactone
6 alpha-Methylcompactin
6 Methylcompactin
6alpha-methylcompactin
6-alpha-methylcompactin
6alpha-Methylcompactin
6-alpha-Methylcompactin
6a-Methylcompactin
6-Methylcompactin
6α-methylcompactin
71949-96-7
74133-25-8
75330-75-5
81739-26-6
AC-13961
AC1L1EI6
AC1Q2C7T
ACon0_000534
ACon1_000390
alpha-Isomer lovastatin, 1
Altocor
Altoprev
ARONIS24208
Artein
BB_NC-1457
Belvas
BIDD:GT0749
BIDD:PXR0113
BPBio1_000519
BRD-K09416995-001-06-8
BRN 3631989
BSPBio_000471
BSPBio_001265
BSPBio_003346
C07074
C24H36O5
CCRIS 8092
CHEBI:40303
CHEMBL503
Cholestra
CID53232
Closterol
Colevix
CPD000673570
CPD-5561
D00359
D008148
DB00227
DivK1c_001032
Hipolip
Hipovastin
HMS1569H13
HMS1792O07
HMS1923O13
HMS1990O07
HMS2089M06
HMS2093O03
HMS503O05
HSDB 6534
I06-1876
IDI1_001032
KBio1_001032
KBio3_002848
L0214
L-154803
Lestatin
Lipdip
Lipivas
|
Lipofren
Liposcler
Lovalip
Lovalord
lovastatin
Lovastatin
Lovastatin & Primycin
Lovastatin (USP/INN)
Lovastatin [USAN:BAN:INN]
lovastatin lactone
Lovastatin, (1 alpha(s*))-isomer
Lovastatin, (1 alpha(S*))-Isomer
Lovastatin, 1 alpha isomer
Lovastatin, 1 alpha-isomer
Lovastatin, 1 alpha-Isomer (without R*/S* notation)
Lovastatina
Lovastatina [Spanish]
Lovastatine
Lovastatine [French]
Lovastatinum
Lovastatinum [Latin]
Lovasterol
Lovastin
Lozutin
LS-46359
M2147_SIGMA
MEGxm0_000398
Mevacor
Mevacor (TN)
Mevinacor
Mevinolin
Mevinolin from Aspergillus sp.
Mevlor
MK 803
MK803
MK-803
ML-530b
ML-530B
MLS000069585
MLS001055358
MolPort-001-739-990
Monacolin K
Monacolin-K
Monakolin K
MSD 803
NCGC00023509-03
NCGC00023509-04
NCGC00023509-05
NCGC00023509-06
NCGC00023509-07
NCGC00023509-08
nchembio742-comp5
nchembio790-comp14
nchembio869-comp12
Nergadan
NINDS_001032
Paschol
Prestwick_819
Prestwick0_000516
Prestwick1_000516
Prestwick2_000516
Prestwick3_000516
Rextat
Rodatin
Rovacor
SAM002589963
Sivlor
SMR000058779
SMR000673570
SPBio_002392
SPECTRUM1503977
Spectrum3_001873
Spectrum5_001294
STK801953
Taucor
Tecnolip
Teroltrat
UNII-9LHU78OQFD
ZINC03812841
|
|
31 |
|
Memantine |
Approved, Investigational |
Phase 4 |
|
19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
19982-08-2
1-amino-3,5-Dimethyladamantane
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-adamantylamine
3,5-Dimethyl-1-aminoadamantane
3,5-dimethyladamantan-1-amine
3,5-Dimethyladamantan-1-ylamine
3,5-dimethyltricyclo(3.3.1.1(3,7))Decan-1-amine
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
3,5-dimethyltricyclo[3.3.1.1~3,7~]decan-1-amine
41100-52-1 (Hydrochloride)
51052-62-1
AB00053600
AC1L1HB7
AKOS000113995
Axura
BBL000737
Biomol-NT_000209
BPBio1_001117
BPBio1_001270
BSPBio_001015
C13736
CBMicro_020348
CHEBI:152523
CHEMBL807
CID4054
D08174
DB01043
DivK1c_000068
DMAA
Ebixa
EU-0053634
Exiba
Exiba (TN)
HMS500D10
HSDB 7327
IDI1_000068
KBio1_000068
KBio2_001087
KBio2_003655
|
KBio2_006223
KBio3_001926
KBioGR_001543
KBioSS_001087
Lopac0_000861
LS-157051
Lundbeck brand OF memantine hydrochloride
Memantin
Memantina
Memantina [INN-Spanish]
memantine
Memantine
Memantine (INN)
Memantine [INN:BAN]
Memantine [INN]
Memantine HCL
Memantine hydrochloride
Memantine Hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
MolPort-002-041-858
Namenda
NCGC00015705-05
NCGC00024782-02
NCGC00024782-03
NINDS_000068
Oprea1_480562
Prestwick0_000978
Prestwick1_000978
Prestwick2_000978
Prestwick3_000978
SPBio_001456
SPBio_002926
Spectrum_000607
Spectrum2_001408
Spectrum3_000923
Spectrum4_001022
Spectrum5_001355
ST057652
STK520682
UNII-W8O17SJF3T
ZERO/006024
|
|
32 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4 |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
33 |
|
Methylprednisolone Acetate |
|
Phase 4 |
|
|
|
34 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
35 |
|
Omega 3 Fatty Acid |
|
Phase 4 |
|
|
|
36 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
37 |
|
Analgesics |
|
Phase 4 |
|
|
|
38 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
39 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
40 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
41 |
|
Antiparkinson Agents |
|
Phase 4 |
|
|
|
42 |
|
Dihydromevinolin |
|
Phase 4 |
|
|
|
43 |
|
Hypolipidemic Agents |
|
Phase 4 |
|
|
|
44 |
|
Lipid Regulating Agents |
|
Phase 4 |
|
|
|
45 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 4 |
|
|
|
46 |
|
Anticholesteremic Agents |
|
Phase 4 |
|
|
|
47 |
|
L 647318 |
|
Phase 4 |
|
|
|
48 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
49 |
|
Sertraline |
Approved |
Phase 3 |
|
79617-96-2 |
68617 |
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-Dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Altruline
apo Sertraline
apo-Sertraline
Apo-Sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
BIDD:GT0768
BIDD:PXR0193
Boehringer ingelheim brand OF sertraline hydrochloride
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
cis-(+)-sertraline
cis-(+)-Sertraline
Cp 51974
CP 51974
D02360
DB01104
DB08567
Esteve brand OF sertraline hydrochloride
FT-0081122
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
HSDB 7037
Hydrochloride, sertraline
|
KBio3_001918
KBioGR_001724
Lacer brand OF sertraline hydrochloride
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
novo Sertraline
Novopharm brand OF sertraline hydrochloride
novo-Sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Prestwick3_001014
ratio Sertraline
Ratiopharm brand OF sertraline hydrochloride
ratio-Sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
sertraline
Sertraline
Sertraline (INN)
sertraline (Zoloft)
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertraline Hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
SMR000596516
SPBio_000385
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
SRE
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
|
|
50 |
|
Hydrocortisone acetate |
Approved, Vet_approved |
Phase 3 |
|
50-03-3 |
|
Synonyms:
21-O-acetylcortisol
Cortisol 21-acetate
|
Hydrocortisone 21-acetate
|
|
Interventional clinical trials:
(show top 50)
(show all 264)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Comparing Ketogenic Diet With the Most Appropriate Antiepileptic Drug- a Randomized Study of Children With Mental Retardation and Drug Resistant Epilepsy |
Unknown status |
NCT00552526 |
Phase 4 |
Antiepileptic drug (AED) |
2 |
Riluzole in Fragile X Syndrome: A Pilot Study Incorporating Biomarker Assay |
Completed |
NCT00895752 |
Phase 4 |
Riluzole |
3 |
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism |
Completed |
NCT01337700 |
Phase 4 |
Milnacipran;Placebo |
4 |
Combining Lovastatin and a Parent-Implemented Language Intervention in a Multimodal Treatment for Fragile X Syndrome |
Completed |
NCT02642653 |
Phase 4 |
Lovastatin |
5 |
Omega 3/6 Fatty Acids for Reading in Children: A Randomised, Double-blind, Placebo-controlled Trial in 9-year-old Mainstream Schoolchildren in Sweden |
Completed |
NCT02557477 |
Phase 4 |
|
6 |
Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population |
Completed |
NCT00207935 |
Phase 4 |
|
7 |
A Sixteen-Week, Randomized, Double Blind, Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Young Adults With Down Syndrome |
Completed |
NCT01112683 |
Phase 4 |
Memantine;Placebo |
8 |
PICO: Phenylalanine and Its Impact on Cognition - Impact of Phenylalanine on Cognitive, Cerebral and Neurometabolic Parameters in Adult Patients With Phenylketonuria |
Recruiting |
NCT03788343 |
Phase 4 |
Placebo |
9 |
Clinical and Cost Effectiveness of Staff Training in Positive Behaviour Support (PBS) for Treating Challenging Behaviour in People With Intellectual Disability: A Cluster Randomised Controlled Trial |
Unknown status |
NCT01680276 |
Phase 3 |
|
10 |
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex |
Unknown status |
NCT01730209 |
Phase 2, Phase 3 |
Everolimus;Placebo |
11 |
Stereotypies and Mental Retardation: Neurobiological Basis |
Unknown status |
NCT00491478 |
Phase 3 |
sertraline |
12 |
Behavioral and Biochemical Mechanisms of Self-Injury |
Unknown status |
NCT00065936 |
Phase 3 |
Naltrexone hydrochloride |
13 |
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome |
Unknown status |
NCT00056329 |
Phase 3 |
Vitamin E;multivitamin;Placebo |
14 |
Randomized Controlled Trial to Evaluate the Effectiveness of Vibration and External Cold (Buzzy Device) for Pain Relief During Venipuncture or Intravenous Cannulation in Children With Intellectual Disability. |
Completed |
NCT02434731 |
Phase 3 |
|
15 |
Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study With an Open-label Extension Period to Investigate the Efficacy and Safety of NT 201 in the Treatment of Children and Adolescents (2-17 Years) With Chronic Troublesome Sialorrhea Associated With Neurological Disorders, and/or Intellectual Disability |
Completed |
NCT02270736 |
Phase 3 |
IncobotulinumtoxinA;Placebo |
16 |
A Six-Month, Multi-Center, Open-Label Study to Assess the Safety and Efficacy of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions |
Completed |
NCT00491894 |
Phase 3 |
Oral Glycopyrrolate Liquid |
17 |
Severe Aberrant Behavior Among Persons With Mental Retardation. Project III: Behavioral Selectivity of Atypical Neuroleptic Drugs: Effects on Cognitive and Social Behaviors |
Completed |
NCT00065273 |
Phase 3 |
risperidone;clozapine;olanzapine |
18 |
Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 |
Completed |
NCT02333305 |
Phase 3 |
|
19 |
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients |
Completed |
NCT02615197 |
Phase 2, Phase 3 |
|
20 |
A Multicentre Randomised Controlled Trial to Assess the Safety and Efficacy of Adding Rituximab to Standard of Care in Treating Acute Antibody-mediated Rejection in Kidney Transplantation |
Recruiting |
NCT03994783 |
Phase 3 |
Rituximab;Methylprednisolone;Intravenous Immunoglobulin |
21 |
A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome |
Recruiting |
NCT03479476 |
Phase 2, Phase 3 |
Placebo Medication;Metformin |
22 |
Decreasing Risk of Psychosis by Sulforaphane: Study Protocol for a Randomized, Double-blind, Placebo-controlled, Clinical Multicenter Trial (DROPS Trial) |
Recruiting |
NCT03932136 |
Phase 3 |
|
23 |
Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic: An Open-Label 12 - Weeks Randomized Controlled Trail |
Not yet recruiting |
NCT04378257 |
Phase 3 |
|
24 |
Randomized, Placebo Controlled Double-blind Study of the Efficacy of Topiramate on the Symptoms of Irritability - Impulsivity, Overeating and Self-harm in a Population of Patients Suffering From Prader Willi Syndrome Over 8 Weeks |
Terminated |
NCT02810483 |
Phase 3 |
Topiramate;Placebo Comparator |
25 |
A Prospective Open Label Randomised Multicentre Study Evaluating the Efficacy & Safety of Rituximab Given Pre-Transplant to Sensitised Renal Allograft Recipients in Addition to a "Standard" Desensitisation Regimen Consisting of PE/IVIG & MMF |
Unknown status |
NCT00371904 |
Phase 2 |
Rituximab;Standard Care |
26 |
An Open Labeled Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Patients With Mental Retardation. It is Self Funded (Patients' Own Funding) Clinical Trial |
Unknown status |
NCT01908400 |
Phase 1, Phase 2 |
|
27 |
Study Safety and Efficacy of of AUTOLOGOUS Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) for the Patient With Duchenne Muscular Dystrophy. It is Self Funded (Patients' Own Funding) Clinical Trial |
Unknown status |
NCT01834040 |
Phase 1, Phase 2 |
|
28 |
Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation |
Completed |
NCT00426595 |
Phase 2 |
Administration of omeprazole suspension;omeprazole administered as a multi-unit-pellet system |
29 |
Augmentation of the Cholinergic System in Fragile X Syndrome: A Double-Blind Placebo-Controlled Randomized Study of Donepezil |
Completed |
NCT01120626 |
Phase 2 |
donepezil;sugar pill |
30 |
Estrogen Receptors Beta (ER-B) as Therapeutic Targets for the Improvement of Cognitive Performance in Fragile-X (TESXF) |
Completed |
NCT01855971 |
Phase 2 |
|
31 |
Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study |
Completed |
NCT02738918 |
Phase 2 |
Nulojix (Belatacept) |
32 |
Effects of Social Gaze Training on Brain and Behavior in Fragile X Syndrome |
Recruiting |
NCT02616796 |
Phase 1, Phase 2 |
|
33 |
Specifying and Treating the Anxiety Phenotype in Autism Spectrum Disorder |
Recruiting |
NCT03279471 |
Phase 2 |
Sertraline;Placebo |
34 |
Microbiota Transfer Therapy for Children With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders |
Recruiting |
NCT04132427 |
Phase 2 |
|
35 |
Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) |
Recruiting |
NCT01773278 |
Phase 2 |
Antioxidants;Cholesterol |
36 |
A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome (FXS) |
Recruiting |
NCT03862950 |
Phase 2 |
Placebo Medication;Metformin |
37 |
A Randomized Double-Blind Controlled Trial of Everolimus in Individuals With PTEN Mutations (RAD001XUS257T) |
Active, not recruiting |
NCT02991807 |
Phase 1, Phase 2 |
RAD001;Placebo |
38 |
Phase II Multicenter 16-Week Randomized Double Blind Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Adolescents and Young Adults With Down Syndrome |
Active, not recruiting |
NCT02304302 |
Phase 2 |
Memantine;Placebo |
39 |
Use of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot Study |
Not yet recruiting |
NCT04381897 |
Phase 2 |
N-acetyl cysteine |
40 |
Evaluating Assessment and Medication Treatment of ADHD in Children With Down Syndrome |
Not yet recruiting |
NCT04219280 |
Phase 1, Phase 2 |
Quillivant XR;Placebos |
41 |
Phase II Study of Stereotypes and Mental Retardation: Neurobiological Basis |
Suspended |
NCT00004300 |
Phase 2 |
bromocriptine;sertraline hydrochloride |
42 |
Manipulating the Gut Microbiome Study |
Terminated |
NCT03181828 |
Phase 1, Phase 2 |
Acetohydroxamic Acid Oral Tablet [Lithostat] |
43 |
PREDICTORS (Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts) |
Completed |
NCT02567357 |
Phase 1 |
|
44 |
A Phase One Treatment Trial of the Circadian Sleep Disturbance in Smith-Magenis Syndrome (SMS) |
Completed |
NCT00506259 |
Phase 1 |
dTR Melatonin (NIH CC PDS);Melatonin CR |
45 |
Pharmacokinetics of Orally Administered Dasotraline in Subjects With Mild, Moderate, and Severe Hepatic Dysfunction |
Completed |
NCT02795637 |
Phase 1 |
dasotraline |
46 |
Cross-Species Multi-Modal Neuroimaging to Investigate GABA Physiology in Fragile X Syndrome |
Recruiting |
NCT04308954 |
Phase 1 |
[18F]flumazenil |
47 |
Stem Cell Therapy in Mental Retardation |
Withdrawn |
NCT02245724 |
Phase 1 |
|
48 |
Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study |
Unknown status |
NCT02862808 |
|
|
49 |
Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community |
Unknown status |
NCT02214745 |
|
|
50 |
Evaluation of Tools for the Simultaneous Detection of Point and Structural Mutations in Patients With Intellectual Disability |
Unknown status |
NCT02881333 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Buspirone
|
buspirone hydrochloride
|
|